Aaron Lorenzo

Cubist, ZymoGenetics Price Public Offerings, Add Cash

Oct. 17, 2003

By Aaron Lorenzo

Cubist, ZymoGenetics Price Public Offerings, Add Cash

Oct. 17, 2003

By Aaron Lorenzo

With Increasing Product Sales, Genzyme Beats Q3 Estimates

Oct. 16, 2003

By Aaron Lorenzo

Genzyme Corp. beat consensus earnings estimates for the third quarter, without taking into account the company's purchase of SangStat Medical Corp., and raised its fourth-quarter and year-end financial outlook. (BioWorld Today)

With Increasing Product Sales, Genzyme Beats Q3 Estimates

Oct. 16, 2003

By Aaron Lorenzo

Genzyme Corp. beat consensus earnings estimates for the third quarter, without taking into account the company's purchase of SangStat Medical Corp., and raised its fourth-quarter and year-end financial outlook. (BioWorld Today)